This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Innovation, development, and licensure of improved influenza vaccines: the way forward.
Vaccine · 2026
Epistasis facilitates the long-term antigenic evolution of the influenza B virus hemagglutinin.
bioRxiv : the preprint server for biology · 2026
Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2.
Journal of virology · 2025
Latest funding
- $1,212,526
Optimizing treatments for influenza in vulnerable populations using an immunocompromised ferret model.
CIHR · 2026 · Co-investigator
- $150,000
Is treatment with a combination of licensed influenza antivirals superior to monotherapy for highly pathogenic H5N1 influenza virus from cattle?
CIHR · 2024 · Co-investigator
- $20,000
International Symposium on Avian Influenza
CIHR · 2024 · Co-investigator
6 publications.
Innovation, development, and licensure of improved influenza vaccines: the way forward.
Ostrowsky JT, Gellin BG, Cavaleri M, Bresee JS, Venkayya R, Cox RJ, Schultz-Cherry S, Hollingsworth R, Subbarao K, Cohen C, Settembre EC, Belongia E, McCauley JW, Rappuoli R, Cowling BJ, Taaffe J, Vestin NC, Mehr AJ, Ulrich AK, Osterholm MT, Moore KA
Epistasis facilitates the long-term antigenic evolution of the influenza B virus hemagglutinin.
Schwab LSU, Xie R, Reilly E, Aban M, Hu S, Spirason N, Deng YM, Suryadinata R, Galiano M, Gartner MJ, Subbarao K, Laurie K, Rockman S, Kent SJ, Wheatley AK, Barr IG, Dhanasekaran V, Koutsakos M
Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2.
Farrukee R, Mordant F, Mackenzie-Kludas C, Mesner D, Yamomoto M, Jolly C, Brooks AG, Subbarao K, Londrigan SL, Reading PC
Contemporary seasonal human coronaviruses display differences in cellular tropism compared to laboratory-adapted reference strains.
Gartner MJ, Smith ML, Dapat C, Liaw YW, Tran T, Suryadinata R, Chen J, Sun G, Shepherd RA, Taiaroa G, Roche M, Lee WS, Robinson P, Polo JM, Subbarao K, Neil JA
Severe acute respiratory syndrome coronavirus-2 shedding in exhaled material: a systematic review.
Abeykoon AMH, Wilson M, Subbarao K, Geard N, Zachreson C, Sullivan SG
Implications of the apparent extinction of B/Yamagata-lineage human influenza viruses.
Barr IG, Subbarao K
Optimizing treatments for influenza in vulnerable populations using an immunocompromised ferret model.
Principal investigators: Baz Etchebarne, Mariana
Keywords: Aerosol Transmission; Antiviral; Antiviral Resistance; Epithelial Cells; Ferrets; Histopathology; Immunomodulators; Influenza Virus; Pathogenesis; Transcriptomics
Is treatment with a combination of licensed influenza antivirals superior to monotherapy for highly pathogenic H5N1 influenza virus from cattle?
Principal investigators: Baz Etchebarne, Mariana
Keywords: Aerosol Transmission; Antiviral Resistance; Bioinformatics; Fda Approved Antivirales; Hamsters; Highly Pathogenic Avian Influenza; Histopathology; Nose And Small And Large-Airway; Pathogenesis; Zoonotic Viruses
International Symposium on Avian Influenza
Principal investigators: Lang, Andrew S
Keywords: One Health; Pandemic Preparedness; Vaccines; Virology; Zoonotic Diseases
Canada Research Excellence Chair in Biology and Control of Zoonotic and Pandemic Respiratory Viruses
Principal investigators: Subbarao, Kanta
Keywords: Cerc
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.